Electroencephalographic Biomarker Detection For Dementia Using Convolutional Neural Network-Based Analysis: A Causal And Outcome-Oriented Study

Abstract

Dementia encompasses a spectrum of progressive neurodegenerative conditions that gradually erode memory, cognitive abilities, and behavioral functioning, severely diminishing quality of life. Traditional diagnostic practices often rely on clinical assessments and neuroimaging, which may be costly or lack early-stage sensitivity. In contrast, electroencephalography (EEG) has emerged as a non-invasive, cost-effective tool capable of capturing subtle neural abnormalities linked to cognitive decline.

With the rise of artificial intelligence (AI), particularly deep learning, novel approaches have surfaced for analyzing complex biomedical data. Among them, Convolutional Neural Networks (CNNs)—renowned for their strength in image and signal processing—offer significant promise in interpreting EEG signals for dementia detection. By learning spatial and temporal patterns directly from EEG recordings, CNNs can identify characteristic changes in brain activity associated with various stages of dementia.

This paper delves into the dual facets of this approach: the cause, examining why EEG signals are suitable for dementia diagnosis and how CNNs process them; and the effect, exploring the practical outcomes, clinical relevance, and challenges of adopting this methodology. We first investigate the neurophysiological alterations induced by dementia and their manifestations in EEG patterns. Early and precise identification of these signatures is crucial for timely intervention and improved long-term care.

Through comprehensive literature analysis and empirical findings, we highlight how CNN-based models consistently outperform traditional machine learning techniques and even expert evaluations in some scenarios. The adoption of such systems in clinical and research environments has shown promising outcomes—ranging from increased diagnostic accuracy and early detection capabilities to economic scalability and improved patient management.

Nonetheless, this paradigm is not without limitations. Issues such as inter-subject variability in EEG data, black-box behavior of deep learning models, and ethical implications surrounding data privacy and algorithmic fairness must be addressed. To that end, we propose forward-looking strategies, including multi-modal diagnostic frameworks, federated learning for privacy-preserving model training, and the development of explainable AI (XAI) to foster transparency and trust.

Ultimately, integrating EEG with CNN-based analysis holds transformative potential in redefining how dementia is detected and managed—offering a pathway toward accessible, scalable, and non-invasive neurological diagnostics.